 In this video, we're going to talk about a billionaire fund buying this penny stock. We'll go right into the information, the research for you. I think that this stock could easily run up, and we'll go through the reasons why I think that. Okay, and I think it's going to run up. We've been right on many penny stocks recently, and I've got to say, I'm a human. I'm not always going to be right all the time, but I've been right a lot recently. We'll go into the information that I've got for you in this video. I've got to say I'm not a financial advisor. I am a business teacher in my daily life, but I'm by no means an expert on the stock market. So let's get right into the information. If you could leave a like on the video at some point, it'd be fantastic. This is our fourth video today, so we are really meeting a lot of videos here, and I am starting to get absolutely tired. But we'll get into the information. Let's get right into it. Okay, so investing, inventing the future of finance. Okay, so this is 0.72, a fund which is actually invested in this penny stock that I'll talk about, but just a bit about them. So they invest in discretionary long short macro and systematic strategies. We're inventing the future of finance by revolution, how we develop our people and how we use our data to shape our thinking. Join our team to innovate, experiment, and be the best at what you do. So this billionaire fund is invested in this penny stock, and sometimes there's a lot of these billionaires that don't always invest in penny stocks that it's quite rare to see, so I want to bring this video to you as fast as I possibly can as I found out the news. So let's go into this information. So we've got C-O-C-P which is the stock that they've bought. They've bought 2.6 million there in terms of funds there, and it's actually 4.1% of their portfolio there I believe. So you've seen here in terms of the increase, they've bought a lot of this penny stock. The billionaire fund has bought a lot of this penny stock. Now who are they? So who are C-O-C-P? We'll go through that in this video so let's have a look. But before we do that I've got to say because we've been right on so many penny stocks and I know I've got, we're starting to build a lot of subscribers here, what I want to make sure you do, as a subscriber make sure that you've got this notification bell turned on. That means you get a notified as soon as I create a video, and as you know, as you all know, with penny stocks they can run up fast. And if you turn on the notification bell you get first hand choice for the video. You know you get first hand updates on the video and you get to see the video first. So turn on the notifications so you see the video first, that'd be fantastic. Also like the video if you appreciate the grind of me producing a lot of these videos. You can tell by the eyes I'm tired. Okay I really but we'll get carry on. And also subscribe to the channel if you're new as well. Okay so thank you for all that support. We'll get back into the stock for you. So what we've got for you is Co-Crystal Pharma and this is a part of their investor presentation. Now this billionaire fund is investing into a company called Co-Crystal Pharma. So let's go into this. So who are they? So they target solutions for viral diseases in terms of novel anti-viral therapeutics for the treatment of seriosund or chronic viral diseases including influenza and some of these ones here as it mentions here. Very big market for this sort of relief right in terms of viral diseases. So what do they do? So Co-Crystal Pharma, Co-Crystal Pharma you've got in terms of clinical stage, it's in that you know you've got the clinical stage, proprietary drug discovery, and that collaboration and potential for for this that and these are the target diseases they're looking at. They're doing their research, they're doing their development into these areas and these potential areas here okay these are widespread as we know. These are areas that are widespread, what does that mean? These need widespread solutions and this is what Co-Crystal are trying to build towards here. So investor highlights what have we got here? So it's applying proprietary structured based drug design technology to develop first and best in class broad spectrum anti-viral drugs. It's got a large market opportunity for the treatment of acute and chronic viral diseases including seasonal and pandemic influenza and then you've got these areas here. Product candidates are tested for multiple routes of delivery, robust development pipeline including merit, collaboration, season leadership includes two not noble lowerites and biotech veterans with proven success in drug discovery and there's a cost efficient business model supported by strong cash position and clean capital structure. That's what we like to see with some of these kind of pharmaceutical companies is ones that have got a strong cash position because they need that money why to invest in what they're doing but also it's good that there's a lot of penny stocks that are in the biopharmaceutical industry but they don't have a good strong cash flow or in terms of their their their cash position right. This one actually has a decent level of strong cash position which is important okay moving on. So we've also got here and this is widely forgotten but we have to remember this influenza remains a major US and global concern and what are this company doing they're trying to provide solutions for this particular aspect in terms of influenza so some of the headlines here you've got flu season deaths top 80 000 last year this was in 2018 you've got you know flu seasons that are in terms of the flu is an ongoing problem in itself right influenza and they're trying to provide solutions for this so this has got a lot of shall we say in business terms total addressable market right but also as an ethical concern as well to actually produce stuff that is going to help kind of not deal with the problem but hopefully help the problem right it's got an ethical responsibility to to do what it's doing and it's an interesting company it's involved in research and development in interesting areas there's some biopharmaceutical companies out there which are brilliant but sometimes they're only dealing with a very kind of niche issues right there's still room for them to grow but this is dealing in areas where there's massive problems so this is why I feel that this one could explode it could tank it could explode though it's a penny stock with volatile we have to remember that right some of the investment highlights that we've got today what have we got applying proprietary structure based drug design technology to develop first and best in class spectrum anti-viral drugs okay it manage a large market opportunity for the treatment of acute areas here and we've talked about some of these just now so I've gone and that's how tired I am I'm actually repeating slides but you get the point right so what is this at it's actually sat at here at $2.19 after hours it's up 3.2 percent this one I think is going to get to three to four dollars very quickly okay so you could swing trade it buy it and then sell it right but this could also have the potential to run up to five six seven dollars so you got potential of multitude of hundreds of percent on your investment here I do think it's going to potentially run up certainly much more than the 219 this is going into three dollars without a doubt in my mind so I would consider this as a position anyways guys so that's the end of the video I hope you enjoyed it I hope it was informative if you like the video then do like the video like press the like button and also subscribe to the channel if you're new and remember if you're currently subscribed okay turn on the notification bell so we get you informed on any latest penny stocks obviously you have your own of the sources you do your own due diligence on penny stocks because the volatile I could sometimes be wrong I've been right on quite a few recently penny stocks but there's nothing to say that sometimes I can't be wrong and I'll admit that so okay so thank you for watching the video and make sure to like subscribe and comment let me know what your thoughts are on this stock and I will see everybody in the next video